Advertisement

Pharmacy

Despite an ongoing Ebola outbreak in the Democratic Republic of Congo, GlaxoSmithKline is giving up efforts to develop three vaccines to combat the virus. It will transfer rights to its work to the Sabin Vaccine Institute in the U.S. 

Including inpatient and outpatient environments, hospitals and health systems can expect a 4.57 percent increase in pharmaceutical spending next year, according to Vizient's July 2019 drug price forecast.

OxyContin maker Purdue Pharma plans to close its manufacturing plant in Durham, N.C., by the end of the year, according to the Stamford Advocate.

Advertisement

The FDA has approved Turalio, the first therapy for adult patients with a rare, nonmalignant tumor that affects joints and causes severe morbidity.

RWJBarnabas Health System developed a specialized pharmacy team for its intensive care unit that has reduced medication wait times and potential drug errors in critical care settings, according to a new study published in the Journal of Clinical Outcomes.

Advertisement